1-20 of 59 results for tabledby:"Lord Bethell"
Librarians' tools
- Search time
- 0.282 seconds
- Solr query time
- 0.002 seconds
- Search query
- tabledby:"Lord Bethell"
- We searched for
- tablingMember_ses:299155
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask His Majesty's Government what are the process and criteria for triggering an economic impact assessment of a new disease in the Treasury; and whether they are undertaking an assessment of the suitability of that process and criteria against long Covid, as a condition that did not exist five...
To ask His Majesty's Government what are the process and criteria for triggering an economic impact assessment of a new disease in the Treasury; and whether they are undertaking an assessment of the suitability of that process and criteria against long Covid, as a condition that did not exist five...
HM Treasury has a comprehensive framework for assessing and managing potential risks to the economic and fiscal outlook, including those posed by new diseases. This framework involves systematic monitoring through internal risk monitors, risk governance forums, and collaboration with other government departments such as the Cabinet Office and the Department of Health and Social Care (DHSC). In escalatory scenarios, such as where a new disease with high transmission rates emerges, HM Treasury is prepared to conduct economic impact assessments to inform policy and response plans.
During the COVID-19 pandemic, HM Treasury officials engaged with other Government departments to consider the implications of long COVID, including assisting with preparations for the DHSC long COVID Oversight Board. HM Treasury will provide more information on its efforts to understand the economic implications of long COVID-19 to the ongoing COVID-19 inquiry.
To ask His Majesty's Government what are the process and criteria for triggering an economic impact assessment of a new disease in the Department of Health and Social Care; and whether they are undertaking an assessment of the suitability of that process and criteria against long Covid, as a condition...
To ask His Majesty's Government what are the process and criteria for triggering an economic impact assessment of a new disease in the Department of Health and Social Care; and whether they are undertaking an assessment of the suitability of that process and criteria against long Covid, as a condition...
The Government understands the scale of the challenge presented by long COVID, which is also felt on employment and the economy.
NHS England established over 100 long COVID services for adults, and for children and young people. These assess people with long COVID and direct them into appropriate care pathways which provide appropriate support and treatment.
The Government has also invested over £57 million into long COVID research. The projects aim to improve our understanding of the diagnosis and underlying mechanisms of the disease and the effectiveness of both pharmacological and non-pharmacological therapies and interventions, and to evaluate clinical care.
The Department regularly reviews evidence on the health and economic impact of diseases and conditions. Where appropriate, this evidence is used to produce impact assessments which inform the development of new policies to address the needs of the population.
To ask His Majesty's Government whether they will make an assessment of the impact of the Joint Committee on Vaccination and Immunisation's advice for the Spring and Autumn 2025 COVID-19 vaccination programme on the delivery of their core health shifts.
To ask His Majesty's Government whether they will make an assessment of the impact of the Joint Committee on Vaccination and Immunisation's advice for the Spring and Autumn 2025 COVID-19 vaccination programme on the delivery of their core health shifts.
Vaccination plays an important role in the Government’s Plan for Change and the Health Mission, including in the shift from sickness to prevention. The Government continues to be guided by the independent Joint Committee for Vaccination and Immunisation (JCVI) on the approach to vaccination and immunisation.
The primary aim of the national COVID-19 vaccination programme remains the prevention of severe illness, namely hospitalisations and deaths, arising from COVID-19. On 13 November 2024, the JCVI published advice on the COVID-19 vaccination programme for spring 2025, autumn 2025 and spring 2026. This advice is available on the GOV.UK website, in an online-only format.
On 12 December 2024, the Government accepted the JCVI advice that a COVID-19 vaccine should be offered in spring 2025 to adults aged 75 years old and over, residents in a care home for older adults, and the immunosuppressed aged six months and over. Eligibility for the spring 2025 campaign is the same as in previous spring campaigns.
The JCVI also advised on eligibility for autumn 2025 and spring 2026 programmes. The Government is considering this advice carefully and will respond in due course.
To ask His Majesty's Government what steps they are taking to improve transparency in the decision-making processes of the Joint Committee on Vaccination and Immunisation; and whether this includes publishing detailed evidence underlying its recommendations.
To ask His Majesty's Government what steps they are taking to improve transparency in the decision-making processes of the Joint Committee on Vaccination and Immunisation; and whether this includes publishing detailed evidence underlying its recommendations.
As per the Joint Committee on Vaccination and Immunisation’s (JCVI) code of practice, committee minutes are published within six weeks of the meeting, via its webpage. These minutes outline the information presented to members and summarise the considerations and discussion. The JCVI also publishes advice statements on the GOV.UK website, and these statements outline the advice given and the rationale.
Where possible, data considered by the committee is referenced in minutes and statements. On occasion, data reviewed by the committee may remain unpublished when the minutes are released. This could be due to the data being new, sensitive, or subject to confidentiality. For transparency and public interest, the JCVI encourages all researchers who present to the committee to publish data once appropriate.
To ask His Majesty's Government how their vaccination policies are being aligned with broader public health outcomes, beyond immediate capacity savings in the NHS.
To ask His Majesty's Government how their vaccination policies are being aligned with broader public health outcomes, beyond immediate capacity savings in the NHS.
Vaccination plays an important role in the Government’s Plan for Change and Health Mission, including in the shift from sickness to prevention. The Department works closely with the UK Health Security Agency and NHS England, with expert advice from the Joint Committee on Vaccination and Immunisation, to design, implement, and deliver 17 programmes offering high levels of long-term protection. These include seasonal and routine programmes as set out in the national schedule.
Our vaccination and immunisation programmes therefore support multiple public health objectives, including contributing to efforts to eliminate or eradicate disease, prevent outbreaks of infectious disease, reduce the burden of ill-health, and to reduce health inequalities, for example by ensuring that targeted outreach can offer vaccinations to underserved populations.
To ask His Majesty's Government what plans they have to evolve the Joint Committee on Vaccination and Immunisation's methods to assess the broader socio-economic benefits of vaccination.
To ask His Majesty's Government what plans they have to evolve the Joint Committee on Vaccination and Immunisation's methods to assess the broader socio-economic benefits of vaccination.
As an independent Departmental Expert Committee, the Joint Committee on Vaccination and Immunisation (JCVI) advises the Department on matters related to vaccination and immunisation. The JCVI bases its advice and recommendations on evidence of the burden of disease, of vaccine safety and efficacy, and of the impact and cost effectiveness of immunisation strategies.
Broader socio-economic factors, such as productivity costs from illness, improved educational attainment from reduced school absences, and out-of-pocket expenses and opportunity costs from attending a vaccination, are not included in the cost-effective analysis which is presented to the JCVI for its consideration. However, these impacts may be highlighted by the JCVI to inform policy-making.
To ask His Majesty's Government what are the objectives of the MedTech Directorate of the Department of Health and Social Care; and when they intend to publish the (1) strategy, and (2) workplan, for achieving those objectives.
To ask His Majesty's Government what are the objectives of the MedTech Directorate of the Department of Health and Social Care; and when they intend to publish the (1) strategy, and (2) workplan, for achieving those objectives.
The Directorate aims to ensure that the health and care system has a resilient supply chain for safe and high quality products, provides value for money, embeds sustainability, has access to and adoption of innovative products and a managed transition for medical technology issues following the United Kingdom’s exit from the European Union and the recovery from the COVID-19 pandemic.
The Directorate has engaged with industry on the Medtech strategy, which is due to be published shortly and is establishing a governing board to oversee the strategy’s implementation. Further information on the implementation of the strategy will be available early in the new year.
What action they have taken as the result of alleged abuses and fraud identified in a letter from European Community Commissioner Gradin to Mr David Blunkett; and in particular, what plans the Metropolitan Police and the District Auditor of Camden have to investigate these allegations. [HL 4119].
What action they have taken as the result of alleged abuses and fraud identified in a letter from European Community Commissioner Gradin to Mr David Blunkett; and in particular, what plans the Metropolitan Police and the District Auditor of Camden have to investigate these allegations. [HL 4119].
On what date Sir John Freeland was most recently appointed as a judge to the European Court of Human Rights; on what date he relinquished that appointment; and whether his duties concerned exclusively the case Matthews v. United Kingdom. [HL 1928].
On what date Sir John Freeland was most recently appointed as a judge to the European Court of Human Rights; on what date he relinquished that appointment; and whether his duties concerned exclusively the case Matthews v. United Kingdom. [HL 1928].
What action they have taken, in the light of the letter dated 23 June 1998 from Mrs Anita Gradin, Member of the European Commission, to the Sec of State for Education and Employment, indicating that 'serious irregularities have occurred in the London Borough of Camden and certain other London boroughs...
What action they have taken, in the light of the letter dated 23 June 1998 from Mrs Anita Gradin, Member of the European Commission, to the Sec of State for Education and Employment, indicating that 'serious irregularities have occurred in the London Borough of Camden and certain other London boroughs...
How much money has been made available from the European Union Budget, in each of the past three years, for cultural projects in the London area; and whether they will give details of each individual project which has received funds. [HL4]. - Inc fig and fact that not possible to...
How much money has been made available from the European Union Budget, in each of the past three years, for cultural projects in the London area; and whether they will give details of each individual project which has received funds. [HL4]. - Inc fig and fact that not possible to...
How much money has been made available from the European Regional Development Fund, in each of the past three years, for each London borough; and whether they will give details of each individual project which has received funds. [HL 2]. - Includes tables.
How much money has been made available from the European Regional Development Fund, in each of the past three years, for each London borough; and whether they will give details of each individual project which has received funds. [HL 2]. - Includes tables.
How much money has been made available from the European Union budget, in each of the past three years, for transport infrastructure in the London area; and whether they will give details of each individual project which has received funds. [HL 3]. - Includes table.
How much money has been made available from the European Union budget, in each of the past three years, for transport infrastructure in the London area; and whether they will give details of each individual project which has received funds. [HL 3]. - Includes table.
How much money has been made available from the European Social Fund, in each of the past 3 years, for each of the London boroughs; and whether they ill give details of each individual project which has received funds. - Includes table of total grants and that details of individual...
How much money has been made available from the European Social Fund, in each of the past 3 years, for each of the London boroughs; and whether they ill give details of each individual project which has received funds. - Includes table of total grants and that details of individual...
Whether they approve the principle of an elected upper house, or second chamber, of parliament; whether they believe that members of an elected upper house, or second chamber, should be remunerated and provided with secretarial and research assistance at a level enjoyed by Members of the House of Commons; and...
Whether they approve the principle of an elected upper house, or second chamber, of parliament; whether they believe that members of an elected upper house, or second chamber, should be remunerated and provided with secretarial and research assistance at a level enjoyed by Members of the House of Commons; and...
Whether they are aware of conditions in Gibraltar prison; and, if so, what plans they have to improve them.
Whether they are aware of conditions in Gibraltar prison; and, if so, what plans they have to improve them.
What representations HMG have made to the Government of the Ukraine over their refusal to allow Mr Vladimir Raigorodsky of Kharkov to emigrate; whether they have raised the case in the political co-operation machinery of the European Union or with Ukrainian officials in the human rights machinery of the Council...
What representations HMG have made to the Government of the Ukraine over their refusal to allow Mr Vladimir Raigorodsky of Kharkov to emigrate; whether they have raised the case in the political co-operation machinery of the European Union or with Ukrainian officials in the human rights machinery of the Council...
Whether HMG generally favour the idea of co-operating with the security and intelligence services of the Russian Federation as part of the battle against nuclear proliferation, proliferation of weapons of mass destruction, would terrorism, drug dealing and other serious crime.
Whether HMG generally favour the idea of co-operating with the security and intelligence services of the Russian Federation as part of the battle against nuclear proliferation, proliferation of weapons of mass destruction, would terrorism, drug dealing and other serious crime.